Met-Innovfol New Tablet 15's is a combination medicine used to treat diabetic dyslipidaemia (high cholesterol levels in diabetic patients) and poor blood flow. Also, Met-Innovfol New Tablet 15's may be used to treat the polycystic ovarian syndrome. Diabetic dyslipidaemia is a condition associated with high levels of bad cholesterol (low- density lipoprotein), high triglyceride (a type of fat in the blood) levels and low levels of good cholesterol (high-density lipoprotein) in diabetic patients.

Met-Innovfol New Tablet 15's is a combination of two drugs, namely: Metformin (antidiabetic) and Inositol nicotinate (vasodilator). Metformin works by reducing the sugar production by cells in the liver and delays sugar absorption from intestines. Also, it increases the sensitivity of muscle cells to insulin which enables these cells to remove sugar more effectively from the blood. Inositol nicotinate works by widening blood vessels and lower cholesterol levels.

Take Met-Innovfol New Tablet 15's as prescribed by your doctor. You are advised to take Met-Innovfol New Tablet 15's for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience stomach pain, diarrhoea, nausea, vomiting, and loss of appetite. Most of these side effects of Met-Innovfol New Tablet 15's do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Met-Innovfol New Tablet 15's or any other medicines, please tell your doctor. Met-Innovfol New Tablet 15's is not recommended for children below 10 years of age, as the safety and effectiveness were not established. Avoid breastfeeding while taking Met-Innovfol New Tablet 15's and consult a doctor. If you are pregnant or planning for pregnancy, please inform your doctor before taking Met-Innovfol New Tablet 15's. Avoid alcohol consumption with Met-Innovfol New Tablet 15's as it may increase the risk of a life-threatening condition known as lactic acidosis. Drive only if you are alert as Met-Innovfol New Tablet 15's may cause dizziness, weakness or decrease alertness.

Met-Innovfol New Tablet 15's is a combination of two drugs, namely: Metformin and Inositol nicotinate used in the treatment of type 2 diabetes, poor blood flow and diabetic dyslipidaemia (high cholesterol levels in diabetic patients). Also, Met-Innovfol New Tablet 15's may be used to treat the polycystic ovarian syndrome. Metformin decreases the sugar production by cells in the liver and delays sugar absorption from intestines. Also, it increases the sensitivity of muscle cells to insulin which enables these cells to remove sugar more effectively from the blood. Inositol nicotinate works by widening blood vessels and lower cholesterol levels. Proper diet and regular exercise along with Met-Innovfol New Tablet 15's, will give better results.

If you are allergic to Met-Innovfol New Tablet 15's or any other medicines, please tell your doctor. If you have severe infections, uncontrolled diabetes with diarrhoea, lactic acidosis or ketoacidosis (accumulation of ketone bodies in the blood), dehydration, liver, kidney or heart problems, inform your doctor before taking Met-Innovfol New Tablet 15's. Met-Innovfol New Tablet 15's is not recommended for children below 10 years of age, as the safety and effectiveness were not established. Avoid breastfeeding while taking Met-Innovfol New Tablet 15's and consult a doctor. If you are pregnant or planning for pregnancy, please inform your doctor before taking Met-Innovfol New Tablet 15's. Avoid alcohol consumption with Met-Innovfol New Tablet 15's as it may increase the risk of a life-threatening condition known as Lactic acidosis or liver disease. Drive only if you are alert as Met-Innovfol New Tablet 15's may cause dizziness, weakness or decrease alertness. Maintain a low-fat diet along with Met-Innovfol New Tablet 15's for effective results. You are recommended to drink plenty of water while taking Met-Innovfol New Tablet 15's.